These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7506002)

  • 1. A comparison of chondrocyte proteoglycan metabolism in monolayer and agarose cultures.
    Spirito S; Goldberg RL; Di Pasquale G
    Agents Actions; 1993; 39 Spec No():C160-2. PubMed ID: 7506002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet cultures.
    Xu C; Oyajobi BO; Frazer A; Kozaci LD; Russell RG; Hollander AP
    Endocrinology; 1996 Aug; 137(8):3557-65. PubMed ID: 8754787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor 1 and corticosteroid modulation of chondrocyte metabolic and mitogenic activities in interleukin 1-conditioned equine cartilage.
    Frisbie DD; Nixon AJ
    Am J Vet Res; 1997 May; 58(5):524-30. PubMed ID: 9140562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of cell surface proteoglycan from chondrocytes by interleukin-1.
    Goldberg RL; Spirito S; Doughty JR; Di Pasquale G
    Agents Actions; 1993; 39 Spec No():C163-5. PubMed ID: 8273556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dideoxyforskolin on proteoglycan synthesis and structure in embryonic chick chondrocyte cultures.
    Hu LM; Kemp SF; Peng CF; Elders MJ; Smith WG
    FEBS Lett; 1990 Sep; 270(1-2):100-4. PubMed ID: 2171982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glycosaminoglycan metabolism of chondrocyte monolayer cultures under normal and pathological conditions. A methodic study.
    Kittlick PD; Engelmann D; Neupert G
    Exp Pathol; 1991; 41(2):98-109. PubMed ID: 2037034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of R and S enantiomers and a racemic mixture of carprofen on the production and release of proteoglycan and prostaglandin E2 from equine chondrocytes and cartilage explants.
    Armstrong S; Lees P
    Am J Vet Res; 1999 Jan; 60(1):98-104. PubMed ID: 9918155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor binding proteins (IGF-BPs) in bovine articular and ovine growth-plate chondrocyte cultures: their regulation by IGFs and modulation of proteoglycan synthesis.
    Sunic D; Belford DA; McNeil JD; Wiebkin OW
    Biochim Biophys Acta; 1995 Aug; 1245(1):43-8. PubMed ID: 7544626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catabolin/interleukin-1 regulation of cartilage and chondrocyte metabolism.
    O'Byrne EM; Schroder HC; Stefano C; Goldberg RL
    Agents Actions; 1987 Aug; 21(3-4):341-4. PubMed ID: 3500596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture.
    Arner EC; Pratta MA
    Arthritis Rheum; 1989 Mar; 32(3):288-97. PubMed ID: 2784682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiated cellular function in fetal chondrocytes cultured with insulin-like growth factor-I and transforming growth factor-beta.
    Nixon AJ; Lillich JT; Burton-Wurster N; Lust G; Mohammed HO
    J Orthop Res; 1998 Sep; 16(5):531-41. PubMed ID: 9820275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effect of interleukin 6 and interleukin 1 on collagenase and proteoglycan production by chondrocytes.
    Kandel RA; Petelycky M; Dinarello CA; Minden M; Pritzker KP; Cruz TF
    J Rheumatol; 1990 Jul; 17(7):953-7. PubMed ID: 2170644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and mitogenic activities of insulin-like growth factor-1 in interleukin-1-conditioned equine cartilage.
    Frisbie DD; Sandler EA; Trotter GW; McIlwraith CW
    Am J Vet Res; 2000 Apr; 61(4):436-41. PubMed ID: 10772110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants.
    Luyten FP; Hascall VC; Nissley SP; Morales TI; Reddi AH
    Arch Biochem Biophys; 1988 Dec; 267(2):416-25. PubMed ID: 3214163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation by transforming growth factor-beta 1 and interleukin-1 beta of proteoglycan release and chondrodisaccharide composition in porcine articular cartilage.
    Zanni M; Tamburro A; Santone I; Rotilio D
    Semin Thromb Hemost; 1994; 20(2):159-67. PubMed ID: 7997887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loading-induced changes in synovial fluid affect cartilage metabolism.
    van de Lest CH; van den Hoogen BM; van Weeren PR
    Biorheology; 2000; 37(1-2):45-55. PubMed ID: 10912177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a benzylidene derivative, novel antirheumatic agent, on the production of tissue inhibitor of metalloproteinases.
    Watanabe K; Hayashi H; Mori Y
    Biol Pharm Bull; 1994 Jan; 17(1):58-61. PubMed ID: 8148818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines.
    Tyler JA
    Biochem J; 1989 Jun; 260(2):543-8. PubMed ID: 2788408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chondrocytes and antirheumatic drugs.
    Raiss RX; Karbowski A; Aigner T; Schleyerbach R
    J Rheumatol Suppl; 1995 Feb; 43():152-4. PubMed ID: 7538587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.